Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy

Patients with multiple myeloma (MM) who do not respond to initial therapy have worse outcomes than primary responders, and effective treatments are lacking in this population. However, the outcomes of primary refractory disease in the modern treatment era have not yet been studied. We reviewed patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Charalampous, Charalampos, Goel, Utkarsh, Kapoor, Prashant, Binder, Moritz, Buadi, Francis K., Cook, Joselle, Dingli, David, Dispenzieri, Angela, Fonder, Amie L., Gertz, Morie A., Gonsalves, Wilson, Hayman, Suzanne R., Hobbs, Miriam A., Hwa, Yi L., Kourelis, Taxiarchis, Lacy, Martha Q., Leung, Nelson, Lin, Yi, Warsame, Rahma, Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432608/
https://www.ncbi.nlm.nih.gov/pubmed/37603349
http://dx.doi.org/10.1182/bloodadvances.2023009681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432608/
https://www.ncbi.nlm.nih.gov/pubmed/37603349
http://dx.doi.org/10.1182/bloodadvances.2023009681

Ejemplares similares